The Hydroponics Company
The Hydroponics Company THC is at the forefront of developing a leading, diversified, worldwide cannabis business, focused on three core business units.
  • NZ$578,490

    invested

  • 10.5% funded

  • 0

    time left

  • 30.3% - 41.1%

    min - max equity offered

  • NZ$5,500,000 - NZ$8,800,000

    min - max investment sought

  • NZ$2,200.00

    min investment parcel

OFFER IS CLOSED
Note! The Hydroponics Company Limited (THC) is undertaking an initial public offering (IPO) in Australia, and is scheduled to list on the ASX in April 2017. Investors should download and read the prospectus below before investing in the offer. The Australian Corporations Act prohibits any person from passing on to another person the Application Form unless it is accompanied by or attached to a complete copy of this Prospectus. The shares will list and trade on the ASX in Australian Dollars. The IPO offer is at AU$0.20 and investment is being accepted through the Equitise Platform at the price of NZ$0.22 For Australian Investors, Equitise acts as a Corporate Authorised Representative of Lodge Partners Pty Ltd (AFSL: 246271). For New Zealand Investors, the offer is made through the Equitise platform pursuant to the New Zealand equity crowdfunding regime governed by the Financial Markets Conduct Act 2013 and our licence issued by the Financial Markets Authority. This means, that despite the wording in the Prospectus which originally limited the offer in New Zealand to certain qualifying investors, this offer is open to any person in New Zealand entitled to invest through our platform. Please also read carefully the warning statement at the bottom of this offer page which applies to all crowdfunding offers through our platform.
A

a

Offer overview

Initial Public Offering of 25,000,000 Shares in The Hydroponics Company Limited (THC) at an issue price of A$0.20 per Share to raise a minimum of A$5,000,000 with attaching Options on a 1 for 2 basis. 

Investments through the Equitise platform are for a minimum of A$2,000 and a maximum of A$5,000. 

Oversubscriptions for up to 15,000,000 Shares with attaching Options on a 1 for 2 basis may be accepted to raise up to an additional A$3,000,000.

The Prospectus is an important document that should be read in its entirety. If you have any queries or do not understand it you should consult your professional advisers without delay.

Summary

* Fully paid Shares with one Option for nil consideration for every two Shares allotted

** 26,500,000 additional Performance Shares will be issued to Vendors. Performance Shares convert to Shares as specified milestones are achieved. The terms and conditions of the Performance Shares are detailed in Section 9.6 of the Prosepctus.

 Offer Overview

 * Fully paid Shares with one option for nil consideration for every two shares allotted

Timetable

N.B. These dates are indicative only and may vary. The Company, in conjunction with the Lead Manager reserves the right to vary any of the dates without prior notice subject to the Corporations Act and ASX Listing Rules.  

Executive summary

The Hydroponics Company Limited (THC) is an Australian public company that was formed to be a leader in the development and delivery of medicinal cannabis; worldwide manufacturer and distributor of hydroponics equipment, materials and nutrients; and large-scale hydroponic greenhouse design and construction.

The burgeoning market in North America and liberalized laws surrounding cannabis production have created a high demand for the Company's hydroponic product line. The sector is experiencing strong growth as laws are passed in Australia, New Zealand, US and Canada permitting the possession and consumption of cannabis either for medicinal or recreational purposes.

The projected total economic impact of the US Cannabis Industry is estimated to be between US$24.4 and US$44 billion for 2020 representing a 250% increase over 2016 (Source: The State of Legal Marijuana Markets – 4th Edition (Mid-Year Update)).

The Company’s business is summarised in the Investor Presentation (refer to the documents section of this offer). Further and fuller details can be found in Section 2 of this Prospectus.

The Company has concluded several agreements to acquire and/or collaborate with several companies, technologies or projects that are aligned with the objectives of THC. 

Business model
Milestones & history
Strategy & vision
Use of funds
Financial summary
FINANCIAL MARKETS CONDUCT REGULATIONS - WARNING STATEMENT ABOUT EQUITY CROWDFUNDING
  • Equity crowdfunding is risky.
  • Issuers using Equitise’s facility include new or rapidly growing ventures. Investment in these types of businesses is very speculative and carries high risks.
  • You may lose your entire investment, and must be in a position to bear this risk without undue hardship.
  • New Zealand law normally requires people who offer financial products to give information to investors before they invest. This requires those offering financial products to have disclosed information that is important for investors to make an informed decision.
  • The usual rules do not apply to offers by issuers using Equitise’s facility. As a result, you may not be given all the information usually required. You will also have fewer other legal protections for this investment.
  • Ask questions, read all information given carefully, and seek independent financial advice before committing yourself.
Executive summary
Market overview
Target market
Competitive landscape
Potential returns
FINANCIAL MARKETS CONDUCT REGULATIONS - WARNING STATEMENT ABOUT EQUITY CROWDFUNDING
  • Equity crowdfunding is risky.
  • Issuers using Equitise’s facility include new or rapidly growing ventures. Investment in these types of businesses is very speculative and carries high risks.
  • You may lose your entire investment, and must be in a position to bear this risk without undue hardship.
  • New Zealand law normally requires people who offer financial products to give information to investors before they invest. This requires those offering financial products to have disclosed information that is important for investors to make an informed decision.
  • The usual rules do not apply to offers by issuers using Equitise’s facility. As a result, you may not be given all the information usually required. You will also have fewer other legal protections for this investment.
  • Ask questions, read all information given carefully, and seek independent financial advice before committing yourself.
Benjamin Amzalak

See profile
Alan Beasley

See profile

Prospectus

THC Prospectus

Download

The investors below have committed capital to the business in this funding round.

Jonny Wilkinson

See profile
Jianlei Han

See profile
Matthew Kawecki

See profile
Robert Cohen

See profile
Sarah Quinn

See profile
Sue-Maree Kawecki

See profile
Merlin Allan

See profile
Gleneagle 73
Sufian Ahmad

See profile
Mieczyslaw Kawecki

See profile
Tiaan Stals

See profile
Robbie Taylor

See profile
Justus Stals

See profile
Charles Read

See profile
staticnoise
Sean Crilly

See profile
MM
Gleneagle 74
ruby feilich

See profile
MATTHEW QUINN

See profile
Brent Coxon

See profile
traderjezzy
Eugene De Francesco

See profile
Pamela Green

See profile
Michael McQuade

See profile
Olivia Bowen

See profile
rICHARD gOATCHER

See profile
Margaret Loffler

See profile
Sigrid Gollob
YZB
Joshua Borenstein

See profile
Wendy Ming-Yee Cheng

See profile
Gage Milecki

See profile
Justin Stals

See profile
Marc Spicer

See profile
John
techlaggard
Elzbieta Giebartowska

See profile
Phillip Muhlbauer

See profile
lewi_2000
Larry Buono

See profile
Brendan Ede

See profile
Bert Rosenberg

See profile
Bernardo Bilotta

See profile
Tony Horne

See profile
Muhannad alwahb

See profile
Hanna Gammon

See profile
Murray Pearce

See profile
andy Jameson

See profile
William John Lamb

See profile
Claudia Feilich
DAF J

See profile
Carrie Roach

See profile
Debasish Bose

See profile
Lachlan Renshaw

See profile
Nathan Ellis

See profile
Justin Rosenberg

See profile
Scromicle
Josh Bradford

See profile
Bretto
Daniel Clarke

See profile
Kenny Sew Hee

See profile
Shiraz Lateef

See profile
ANDREW ROACH

See profile
C Lee

See profile
david limburg

See profile
Daniel Raihani

See profile
Eli Ekman

See profile
njc
SL
clairejack
JS
Investment baker
Andy Thomson

See profile
Jonathan Pearce

See profile
Daniel Steadman

See profile
Peter Cozens

See profile
Jessica Sturme

See profile
Harry Edwards

See profile
John So

See profile
NICOLA O'NEILL

See profile
Bill Smirniotis

See profile
peter hardi

See profile
Jingjing Chen

See profile
Nicola Rosenberg

See profile
Chris Adelaide
Kane Fisher

See profile
jacqueline feilich

See profile
Camillia Zulinska

See profile
Samantha Bowen

See profile
cdtext
Luke
Simon Feilich
noam field

See profile
Sadia Faraz

See profile
Goldie
Eden Tehan

See profile
Eliezer Jacobs

See profile
ben feilich

See profile
Karen Bowen

See profile
Ron Bowen

See profile
Clever1
Kevin D'Souza

See profile
Simon Peterdawood

See profile
John Isaac

See profile
Kate Edwards

See profile
Rabia Athar

See profile

No comments added yet

 


 


Log in to find out more


Login Register

Please make sure you have saved your campaign before leaving this page